|
Market Closed -
NYSE
04:00:00 2026-09-16 pm EDT
|
5-day change | 1st Jan Change | ||
| 2.680 USD | +0.75% |
|
+0.37% | +48.89% |
| Market Cap | 216M 187M 177M 161M 301M 20.71B 303M 2.11B 816M 10.51B 811M 793M 33.49B | P/E 2026 * |
11.2x | P/E 2027 * | 53.6x |
|---|---|---|---|---|---|
| Enterprise Value | 216M 187M 177M 161M 301M 20.71B 303M 2.11B 816M 10.51B 811M 793M 33.49B | EV / Sales 2026 * |
2.63x | EV / Sales 2027 * | 3.25x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed | |
|
Boerse Muenchen
| PBDA | Real-time |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +0.75% | ||
| 1 week | +0.37% | ||
| Current month | +4.28% | ||
| 1 month | +20.72% | ||
| 3 months | +30.10% | ||
| 6 months | -6.62% | ||
| Current year | +48.89% |
| 1 week | 2.62 |  | 2.79 |
| 1 month | 2.28 | | 2.79 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Free | Director | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chief Executive Officer | 480,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | +0.37% | +37.44% | +51.41% | 216M | |
| +0.15% | +1.21% | +48.79% | +97.65% | 1,014B | |
| +0.03% | +0.07% | +51.47% | +65.55% | 644B | |
| -0.20% | +4.62% | +21.39% | +72.57% | 464B | |
| +0.53% | +4.26% | +40.29% | +38.70% | 354B | |
| +0.39% | +2.35% | +17.96% | +23.87% | 265B | |
| +0.17% | +4.17% | +6.96% | +10.93% | 253B | |
| +0.19% | -3.81% | +37.81% | +44.35% | 203B | |
| -1.20% | -5.64% | -24.09% | -59.10% | 186B | |
| +0.94% | +1.39% | +33.21% | +95.16% | 183B | |
| Average | +0.17% | -0.18% | +27.12% | +44.11% | 356.7B | |
| Weighted average by Cap. | +0.11% | +0.32% | +34.38% | +59.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 71.2M 67.29M 61.09M 115M 7.88B 115M 803M 310M 4B 309M 302M 12.74B | 66.48M 57.61M 54.45M 49.43M 92.65M 6.38B 93.2M 650M 251M 3.23B 250M 244M 10.31B |
| Net income | 19.63M 17.01M 16.08M 14.6M 27.36M 1.88B 27.52M 192M 74.18M 955M 73.75M 72.11M 3.04B | 3.79M 3.29M 3.11M 2.82M 5.29M 364M 5.32M 37.1M 14.34M 185M 14.25M 13.94M 588M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-16 | $2.680 | +0.75% | 1,059,291 |
| 26-09-15 | $2.660 | -3.97% | 812,742 |
| 26-09-14 | $2.770 | +4.92% | 952,160 |
| 26-09-11 | $2.640 | -3.30% | 646,807 |
| 26-09-10 | $2.730 | +2.25% | 782,524 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
